A recent meta-analysis of six studies involving 2071 participants found that GLP-1 RA treatment significantly reduced depression rating scale scores compared to control treatments (standardized mean difference, −0.12; 95% CI, −0.21 to −0.03) [199]. The gene discussed is GLP1R; the disease is depressive disorder.